• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于细胞 SELEX 的针对 V600E 突变黑色素瘤的特异性 ssDNA 适体筛选。

Cell-SELEX-based selection of ssDNA aptamers for specifically targeting V600E-mutated melanoma.

机构信息

Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang North New Area, Shenyang 110122, Liaoning, China.

Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, CAS Research/Education Center for Excellence in Molecular Sciences, institute of chemistry, Chinese Academy of Sciences, 100190, Beijing, China.

出版信息

Analyst. 2021 Dec 20;147(1):187-195. doi: 10.1039/d1an01579f.

DOI:10.1039/d1an01579f
PMID:34874026
Abstract

Malignant melanoma is regarded as the most aggressive form of skin cancer, and is responsible for most death caused by skin cancer. mutations occur in approximately 40-50% of melanomas, with V600E being the most common mutation. Testing for mutations and targeted therapy have markedly improved long-term survival for patients with -mutated melanoma. Here, we report two aptamers, CH1 and CH5 generated by Cell-SELEX, against V600E-mutated human melanoma cells A375. The two aptamers exhibited high affinity to target cells with low dissociation constants () in the nanomolar range. Furthermore, the binding of two aptamers to target cells was independent of incubation temperature, and their molecular targets were demonstrated to be membrane proteins on the cell surface. We also demonstrated that aptamer CH1 was able to bind to metastatic colorectal cancer cells harboring V600E mutation, indicating a relationship between aptamer CH1 and V600E-related metastatic cancer. Owing to the structure stability and high selectivity to V600E-mutated targeting cells, aptamer CH1 holds great potential as a molecular probe for the detection of V600E-mutated metastatic melanoma.

摘要

恶性黑色素瘤被认为是最具侵袭性的皮肤癌,也是导致皮肤癌死亡的主要原因。大约 40-50%的黑色素瘤发生 突变,其中 V600E 是最常见的突变。检测 突变和靶向治疗显著改善了 -突变黑色素瘤患者的长期生存。在这里,我们报告了通过 Cell-SELEX 生成的针对 V600E 突变的人类黑色素瘤细胞 A375 的两个适体 CH1 和 CH5。这两种适体对靶细胞具有高亲和力,解离常数()在纳摩尔范围内。此外,两种适体与靶细胞的结合不依赖于孵育温度,并且它们的分子靶标被证明是细胞表面的膜蛋白。我们还证明,适体 CH1 能够与携带 V600E 突变的转移性结直肠癌细胞结合,表明适体 CH1 与 V600E 相关的转移性癌症之间存在关系。由于结构稳定性和对 V600E 突变靶细胞的高选择性,适体 CH1 有望成为检测 V600E 突变转移性黑色素瘤的分子探针。

相似文献

1
Cell-SELEX-based selection of ssDNA aptamers for specifically targeting V600E-mutated melanoma.基于细胞 SELEX 的针对 V600E 突变黑色素瘤的特异性 ssDNA 适体筛选。
Analyst. 2021 Dec 20;147(1):187-195. doi: 10.1039/d1an01579f.
2
Molecular platforms utilized to detect BRAF V600E mutation in melanoma.用于检测黑色素瘤中BRAF V600E突变的分子平台。
Semin Cutan Med Surg. 2012 Dec;31(4):267-73. doi: 10.1016/j.sder.2012.07.007.
3
Clinicopathological Characteristics of BRAF V600E Mutated Melanomas in the Dalmatian Region of Croatia.克罗地亚达尔马提亚地区BRAF V600E突变黑色素瘤的临床病理特征
Acta Dermatovenerol Croat. 2019 Dec;27(4):225-230.
4
BRAF(V600E) and NRAS(Q61L/Q61R) mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting.使用免疫组织化学对转移性黑色素瘤进行BRAF(V600E)和NRAS(Q61L/Q61R)突变分析:一项754例病例的研究,突出潜在陷阱及解读和报告指南
Histopathology. 2016 Oct;69(4):680-6. doi: 10.1111/his.12992. Epub 2016 Jun 15.
5
Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas.用转移性黑色素瘤的细针抽吸物评估 BRAF 基因 V600E 突变和细胞增殖率。
Anticancer Res. 2010 Sep;30(9):3267-72.
6
Vemurafenib.维莫非尼
Recent Results Cancer Res. 2014;201:215-25. doi: 10.1007/978-3-642-54490-3_13.
7
Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.免疫组织化学法高度敏感和特异,可用于检测黑色素瘤中的 V600E BRAF 突变。
Am J Surg Pathol. 2013 Jan;37(1):61-5. doi: 10.1097/PAS.0b013e31826485c0.
8
Pharmacokinetic Evaluation of [C]CEP-32496 in Nude Mice Bearing BRAF Mutation-Induced Melanomas.携带BRAF突变诱导黑色素瘤的裸鼠中[C]CEP - 32496的药代动力学评估
Mol Imaging. 2018 Jan-Dec;17:1536012118795952. doi: 10.1177/1536012118795952.
9
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells.β-半乳糖苷酶促进癌性神经酰胺代谢酶调节 BRAF(V600E)突变型人黑色素瘤细胞的蛋白质组景观。
Int J Mol Sci. 2023 Jun 23;24(13):10555. doi: 10.3390/ijms241310555.
10
Tumor homogeneity between primary and metastatic sites for BRAF status in metastatic melanoma determined by immunohistochemical and molecular testing.通过免疫组织化学和分子检测确定转移性黑色素瘤中 BRAF 状态的原发和转移部位之间的肿瘤同质性。
PLoS One. 2013 Aug 20;8(8):e70826. doi: 10.1371/journal.pone.0070826. eCollection 2013.

引用本文的文献

1
Revolutionizing tumor diagnosis and treatment: the promise of DNA nanotechnology.革新肿瘤诊断与治疗:DNA纳米技术的前景
Front Immunol. 2025 Aug 29;16:1637539. doi: 10.3389/fimmu.2025.1637539. eCollection 2025.
2
Aptamers as an approach to targeted cancer therapy.适配体作为一种靶向癌症治疗的方法。
Cancer Cell Int. 2024 Mar 16;24(1):108. doi: 10.1186/s12935-024-03295-4.
3
Development and characterization of DNA aptamer against Retinoblastoma by Cell-SELEX.通过细胞 SELEX 技术筛选针对视网膜母细胞瘤的 DNA 适体的开发和鉴定。
Sci Rep. 2022 Sep 28;12(1):16178. doi: 10.1038/s41598-022-20660-3.
4
Graphene Oxide and Fluorescent-Aptamer-Based Novel Aptasensors for Detection of Metastatic Colorectal Cancer Cells.基于氧化石墨烯和荧光适配体的新型适配体传感器用于检测转移性结肠癌细胞
Polymers (Basel). 2022 Jul 27;14(15):3040. doi: 10.3390/polym14153040.